Page last updated: 2024-11-05

2-methylbutanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Methylbutanol is a branched-chain alcohol with the formula CH3CH(CH3)CH2CH2OH. It is a colorless liquid with a characteristic odor and is soluble in water. 2-Methylbutanol can be synthesized through various methods, including the hydroformylation of isobutylene, followed by hydrogenation. It is also produced as a byproduct in the production of other chemicals. 2-Methylbutanol is primarily used as a solvent and intermediate in the production of various chemicals, including plasticizers, resins, and pharmaceuticals. It is also used in the synthesis of perfumes and flavors. 2-Methylbutanol is studied because of its potential use as a biofuel and its application in various industries. Research focuses on its synthesis, properties, and environmental impact. '
```

2-methylbutanol: fragrance; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-methylbutan-1-ol : A primary alcohol that is isopentane substituted by a hydroxy group at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8723
CHEMBL ID451923
CHEBI ID48945
MeSH IDM0552376

Synonyms (81)

Synonym
d-2-methyl-1-butanol
2-methylbutyl alcohol
137-32-6
2-methylbutanol
active primary amyl alcohol
wln: q1y2 & 1
nsc8431
dl-2-methyl-1-butanol
2-methyl butanol-1
primary active amyl alcohol
nsc-8431
sec-butylcarbinol
1-butanol, 2-methyl-
active amyl alcohol
2-methyl-1-butanol
2-methyl-n-butanol
2-methylbutan-1-ol
dl-sec-butyl carbinol
einecs 205-289-9
(1)-2-methylbutan-1-ol
einecs 252-163-4
hsdb 5626
nsc 8431
brn 1718810
ai3-24190
dl-2-methyl-1-butanol, pract
CHEBI:48945 ,
methyl-2-butan-1-ol
ch3ch2ch(ch3)ch2oh
2-methyl-1-butanol, >=99%, fg
2-methyl-1-butanol, natural, 99%, fg
2-methyl-1-butanol, >=99%
FT-0691797
dl-sec-butylcarbinol
M0175
CHEMBL451923
LMFA05000104
NCGC00249069-01
AKOS009159118
ec 205-289-9
ccris 8805
4-01-00-01666 (beilstein handbook reference)
7vtj239asu ,
unii-7vtj239asu
dtxcid107069
cas-137-32-6
NCGC00256976-01
tox21_303200
dtxsid5027069 ,
NCGC00259107-01
tox21_201558
2-methyl-butan-1-ol
FT-0612896
FT-0605210
( inverted exclamation marka)-2-methyl-1-butanol
(+/-)-2-methyl-1-butanol
(+)-2-methylbutanol
(-)2-methylbutanol
2-methyl-butanol
2-methyl 1-butanol
2-methyl-1-butanol,(+/-)-
2-methyl-1-butanol [hsdb]
(+/-)-2-methyl-1-butanol [fhfi]
fema no. 3998
2-methyl-1-butanol [mi]
3-methyl iso-butanol
butanol, 2-methyl-
34713-94-5
J-510045
sec-butyl carbinol
F0001-0469
mfcd00004743
(+/-)-2-methyl-1-butanol, >=98.0% (gc)
2-methyl-1-butanol, analytical standard
2-methyl-(2s)-1-butanol
2-methyl-(s)-1-butanol
2-methyl-(.+/-.)-1-butanol
Q209425
(rs)-2-methyl-1-butanol
EN300-126214
STL185573
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
alkyl alcoholAn aliphatic alcohol in which the aliphatic alkane chain is substituted by a hydroxy group at unspecified position.
primary alcoholA primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Isoleucine Degradation79
L-isoleucine degradation II1212
isoleucine degradation II1312

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency70.13260.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.01720.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency75.97730.000714.592883.7951AID1259369
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency34.96360.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency53.78780.001530.607315,848.9004AID1224841
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.19080.001628.015177.1139AID1259385
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency9.68850.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency65.35740.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's11 (91.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.22 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index78.86 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]